Phage Display Technologies - SMi Conference. 23-24 January 2002, London, UK.
This fairly small meeting, with about 50 attendees, covered all areas of antibody engineering from basic technologies to applications in both therapeutic and diagnostic areas. Despite the fact that nearly all speakers came from commercial organizations, the data presented were solid and highly informative. While new technologies, such as yeast or ribosome display, are integrating into the drug discovery process, vaccine technology looks like a promising alternative to human antibody therapy. New advances in the field, especially in technology, are primarily governed by the tight intellectual property situation.
Jermutus
Lutz
L
Cambridge Antibody Technology Group plc, The Science Park, Melbourn, Royston, Cambridgeshire, SG8 6JJ, UK. lutz.jermutus@cambridgeantibody.com